Amneal Pharmaceuticals AMRX
NASDAQ AMRX
$20.30 +0.23 (+1.15%)
At close: Oct 2, 2026 · 4:00 PM EDT

Amneal Pharmaceuticals (AMRX) Change in Accured Expenses (2017 - 2026)

Updated

Amneal Pharmaceuticals (AMRX) posted Change in Accured Expenses of $66.66 million for Q2 2026, up 46.1% from $45.62 million a year earlier.

Analysis

Amneal Pharmaceuticals (AMRX) Change in Accured Expenses (2017 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Change in Accured Expenses at Amneal Pharmaceuticals was $30.41 million, down 34.0% year-over-year; for FY2025, it came in at $21.32 million, down 90.9% from FY2024.

  • Annual Change in Accured Expenses shows a five-year compound annual growth rate of 133.5% (FY2020 to FY2025).
  • In prior years, Amneal Pharmaceuticals' Change in Accured Expenses was $235.14 million in FY2024, -$94.45 million in FY2023, $109.57 million in FY2022 and -$43.93 million in FY2021.
  • Quarterly Change in Accured Expenses has run from a low of -$150.48 million in Q1 2023 to a high of $322.72 million in Q2 2022 over five years.
  • On a year-over-year basis, Change in Accured Expenses increased in three of the last five quarters, with growth averaging 8.2%.
  • According to Business Quant data, Change in Accured Expenses for the three prior quarters was -$124.58 million (Q1 2026), $18.58 million (Q4 2025) and $69.75 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 2.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -251.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 338.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Amneal Pharmaceuticals 6.48 Bn 5.76 Bn 334.51 Mn 66.66 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 66.66 Mn
Mar 31, 2026 -124.58 Mn
Dec 31, 2025 18.58 Mn
Sep 30, 2025 69.75 Mn
Jun 30, 2025 45.62 Mn
Mar 31, 2025 -112.63 Mn
Dec 31, 2024 66.26 Mn
Sep 30, 2024 46.85 Mn
Jun 30, 2024 59.85 Mn
Mar 31, 2024 62.17 Mn
Dec 31, 2023 -19.76 Mn
Sep 30, 2023 33.08 Mn
Jun 30, 2023 42.72 Mn
Mar 31, 2023 -150.48 Mn
Dec 31, 2022 -55.87 Mn
Sep 30, 2022 -108.51 Mn
Jun 30, 2022 322.72 Mn
Mar 31, 2022 -48.78 Mn
Dec 31, 2021 -11.11 Mn
Sep 30, 2021 -11.68 Mn
API Access

Amneal Pharmaceuticals Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=AMRX&period=max&api_key=YOUR_API_KEY